ArticleBreast cancer (Dove Medical Press)2026
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.
Akira Tsunoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.